Interference with the transcriptional activity of NF‐κB that leads to alterations in the proangiogenic context and the inhibition of proangiogenic gene expression may be promising therapeutic strategies aimed at glioma angiogenesis blocking. Here, NFKB1 is linked to central nervous system cancer.